{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 457630940
| IUPAC_name = IUPAC_name = （6R，7R）-3-甲基-7-[（R）-2-氨基-2-苯乙酰氨基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸 <br /> (7R)-3-Methyl-7- (α- D -phenylglycylamino) -3-cephem-4-carboxylic acid monohydrate
| image = Cefalexin Structual Formula V1.svg
| image2 = Cefalexin ball-and-stick.png

<!--臨床資料-->
| pronounce   = {{IPAc-en|ˌ|s|ɛ|f|ə|ˈ|l|ɛ|k|s|ᵻ|n}}
| tradename = Keflex, Cepol, Ceporexine, Ceporex<ref name=McP2007/>
| Drugs.com = {{Drugs.com|monograph|Cephalexin}} 
| MedlinePlus = a682733
| pregnancy_AU = A
| pregnancy_US = B
| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 口服
| licence_US = Keflex

<!--藥理動力學資料-->
| bioavailability = 吸收良好
| protein_bound = 15%
| metabolism = 80% excreted unchanged in urine within 6 hours of administration
| elimination_half-life = For an adult with normal renal function, the serum half-life is 0.5–1.2 hours<ref>McEvoy, G.K. (ed.). American Hospital Formulary Service — Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 166</ref>
| excretion = [[腎|腎]]

<!--列管編號-->
| IUPHAR_ligand = 4832
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 15686-71-2
| ATC_prefix = J01
| ATC_suffix = DB01
| ATC_supplemental = {{ATCvet|J51|DB01}}
| PubChem = 2666
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00567
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 25541
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5SFF1W6677
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00263
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3534
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1727

<!--化學資料-->
| C=16 | H=17 | N=3 | O=4 | S=1 
| molecular_weight = 347.39 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccccc3)N)C)C(=O)O
| InChI = 1/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
| InChIKey = ZAIPMKNFIOOWCQ-UEKVPHQBBS
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
| melting_point = 326.8
}}

'''頭孢氨苄'''（{{lang-en|Cefalexin}}或{{lang-en|Cephalexin}}，又譯'''先锋霉素Ⅳ'''、又作'''賜福力欣'''、'''頭孢力欣'''、'''賜爾復新'''、'''西華烈信'''、'''施華林'''、'''喜化幸'''、'''雪華力欣、'''或'''賜泛立信'''等<ref>{{cite web |url=http://mrc.hatw.org.tw/search.aspx?key=cafalexin&source=0 |title=衛生福利部病歷中文化字彙查詢 |accessdate=2015-01-10 |archive-date=2016-11-20 |archive-url=https://web.archive.org/web/20161120090735/http://mrc.hatw.org.tw/search.aspx?key=cafalexin&source=0 |dead-url=no }}</ref>）。是一种半合成的第一代口服[[頭孢菌素|头孢霉素类]]類[[抗生素|抗生素]]药物，可用於數種細菌感染的[[抗細菌藥|抗生素]]。頭孢氨苄是口服藥，藉由干擾細菌細胞壁的合成來殺死[[革蘭氏陽性菌|革蘭氏陽性菌]]和部分[[革蘭氏陰性菌|革蘭氏陰性菌]]<ref name="AHFS2014">{{cite web|title=Cephalexin|url=http://www.drugs.com/monograph/cephalexin.html|publisher=The American Society of Health-System Pharmacists|accessdate=2014-04-21|archive-date=2014-05-01|archive-url=https://web.archive.org/web/20140501202910/http://www.drugs.com/monograph/cephalexin.html|dead-url=no}}</ref>。頭孢氨苄屬於[[頭孢菌素#第一代|第一代頭孢菌素]]，它與其他同類的抗生素如靜脈施打的[[頭孢唑啉|頭孢唑啉]]具有相似的作用<ref>{{cite book|last=Brunton|first=Laurence L.|title=Goodman & Gilman's pharmacological basis of therapeutics.|date=2011|publisher=McGraw-Hill|location=New York|isbn=978-0071624428 |edition=12th |chapter=53, Penicillins, Cephalosporins, and Other β-Lactam Antibiotics}}</ref>。 

<!-- 醫療用途 -->
頭孢氨苄被以於治療[[中耳炎|中耳炎]]、[[鏈球菌性咽炎|鏈球菌性咽炎]]、[[肺炎|肺炎]]、骨與關節感染、[[蜂窩性組織炎|蜂窩性組織炎]]、以及[[泌尿道感染|泌尿道感染]]等，它也可以被用於預防[[感染性心內膜炎|感染性心內膜炎]]。頭孢氨苄對於[[抗藥性金黃色葡萄球菌|抗藥性金黃色葡萄球菌]]沒有效果。頭孢氨苄可以使用在對青黴素有輕微至普通程度過敏反應的病人身上，但對於有強烈過敏反應的病人而言則不適合使用。頭孢氨苄對[[病毒感染|病毒感染]]並沒有效果<ref name=AHFS2014/>。在台灣，由於組織穿透性不佳以及抗藥性菌株較多，除蜂窩性組織炎及經確認菌株無抗藥性的泌尿道感染<ref>{{cite journal | title = 台灣門診泌尿道感染抗生素處方型態分析及其影響因素 | url = http://140.113.39.130/cgi-bin/gs32/ymgsweb.cgi/login?o=dymcdr&s=id=%22GYA226035515%22.&searchmode=basic#XXXX | author = 詹雅惠 | publisher = 陽明大學醫務管理研究所 | year = 2006 | accessdate = 2015-01-11 | archive-date = 2017-03-05 | archive-url = https://web.archive.org/web/20170305020719/http://140.113.39.130/cgi-bin/gs32/ymgsweb.cgi/login?o=dymcdr&s=id=%22GYA226035515%22.&searchmode=basic#XXXX | dead-url = no }}</ref>仍使用頭孢氨苄作首選治療藥物，上述其他病症（中耳炎<ref>台灣中耳炎治療現以高劑量阿莫西林為一線用藥，見表5{{cite journal | title = Diagnosis and Treatment of Otitis Media | url = http://www.aafp.org/afp/2007/1201/p1650.html | publisher = American Academy of Family Physicians | accessdate = 2015-01-10 | journal =  | archive-date = 2021-05-06 | archive-url = https://web.archive.org/web/20210506120752/https://www.aafp.org/afp/2007/1201/p1650.html | dead-url = no }}</ref>、咽炎<ref>台灣咽炎治療現以高劑量阿墨西林為一線用藥，{{cite web | title = Diagnosis and Treatment of Streptococcal Pharyngitis | url = http://www.aafp.org/afp/2009/0301/p383.html | publisher = American Academy of Family Physicians | accessdate = 2015-01-10 | archive-date = 2015-02-08 | archive-url = https://web.archive.org/web/20150208124744/http://www.aafp.org/afp/2009/0301/p383.html | dead-url = no }}</ref>、肺炎<ref>肺炎臨床診療指引，{{cite article | title = 國衛院 肺炎治療指引 | page = 72 | url = http://imohw.tmu.edu.tw/idohtmu/wp-content/uploads/2013/04/01%E8%82%BA%E7%82%8E%E8%87%A8%E5%BA%8A%E8%A8%BA%E7%99%82%E6%8C%87%E5%BC%95.pdf | access-date = 2015-01-11 | archive-date = 2018-12-23 | archive-url = https://web.archive.org/web/20181223092108/http://imohw.tmu.edu.tw/idohtmu/wp-content/uploads/2013/04/01%E8%82%BA%E7%82%8E%E8%87%A8%E5%BA%8A%E8%A8%BA%E7%99%82%E6%8C%87%E5%BC%95.pdf | dead-url = no }}；表七{{cite article | title = Infectious Diseases Society of America/AmericanThoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults | url = http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/CAP%20in%20Adults.pdf | year = 2007 | accessdate = 2015-01-11 | archive-date = 2018-07-13 | archive-url = https://web.archive.org/web/20180713070926/http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/CAP%20in%20Adults.pdf | dead-url = no }}</ref>、骨與關節感染<ref>骨與關節感染(septic arthritis與osteomyelitis)也不會用此藥治療，血清濃度可能不夠，組織穿透性也不夠好，詳見下列文獻表四{{cite journal | title = Management of septic arthritis: a systematic review | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856038/ | publisher = Annals of the Rheumatic Diseases | doi = 10.1136/ard.2006.058909 | author = Mathews, C. J., Kingsley, G., Field, M., Jones, A., Weston, V. C., Phillips, M., … Coakley, G. | year = 2007 | access-date = 2015-01-11 | archive-date = 2022-01-19 | archive-url = https://web.archive.org/web/20220119221658/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856038/ | dead-url = no }}以及下列文獻的表三{{cite journal | title = Diagnosis and Management of Osteomyelitis | url = http://www.aafp.org/afp/2011/1101/p1027.html | author = JOHN HATZENBUEHLER, MD, and THOMAS J. PULLING, MD, Maine Medical Center, Portland, Maine | publisher = American Academy of Family Physicians. | access-date = 2015-01-11 | archive-date = 2021-05-11 | archive-url = https://web.archive.org/web/20210511094317/https://www.aafp.org/afp/2011/1101/p1027.html | dead-url = no }}</ref>、以及感染心內膜炎<ref>{{cite journal | title = Prevention of Infective Endocarditis | url = http://circ.ahajournals.org/content/116/15/1736 | doi = 10.1161/CIRCULATIONAHA.106.183095 | year = 2007 | accessdate = 2015-01-11 | journal =  | archive-date = 2018-07-04 | archive-url = https://web.archive.org/web/20180704170747/http://circ.ahajournals.org/content/116/15/1736 | dead-url = no }}</ref>）已經建議使用其他抗生素治療<ref>Harrison's Principle of ...</ref><ref>{{cite journal | url = http://cid.oxfordjournals.org/content/52/5/e103.full.pdf+html | title = International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases | author = Kalpana Gupta, Thomas M. Hooton, Kurt G. Naber, Bjo¨rn Wullt, Richard Colgan, Loren G. Miller, Gregory J. Moran, Lindsay E. Nicolle, Raul Raz, Anthony J. Schaeffer, and David E. Soper | year = 2011 | doi = 10.1093/cid/ciq257 | accessdate = 2015-01-11 | archive-date = 2016-11-26 | archive-url = https://web.archive.org/web/20161126101244/http://cid.oxfordjournals.org/content/52/5/e103.full.pdf+html | dead-url = no }}</ref>。

<!-- 副作用 -->
頭孢氨苄的可能副作用包括[[過敏|過敏]]、腸胃不適、[[偽膜性結腸炎|偽膜性結腸炎]]等等<ref name=AHFS2014/>。對於孕婦而言，本藥品在許多孕婦使用後仍沒有證據顯示它會對孕婦或胎兒造成傷害<ref name=AHFS2014/><ref name=TGA2014>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|accessdate=2014-04-22|date=2014-03-03|archive-date=2014-04-08|archive-url=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|dead-url=no}}</ref>（等同於美國的懷孕用藥等級B；與澳洲的等級A），在哺乳期間使用本藥品也是安全的<ref name=Breast2013>{{cite book|title=Breastfeeding and Medication|date=2013|publisher=Routledge|isbn=9781136178153|page=227|url=http://books.google.ca/books?id=0Y8lbCnF1mgC&pg=PA227|author=Wendy Jones|access-date=2015-01-11|archive-date=2014-12-25|archive-url=https://web.archive.org/web/20141225154700/http://books.google.ca/books?id=0Y8lbCnF1mgC&pg=PA227|dead-url=no}}</ref>。兒童與65歲以上的老人都可以安全的使用本藥。[[腎功能衰竭|腎功能不佳]]的病人在使用本藥品時應依指示減少劑量<ref name=AHFS2014/>。

<!-- 歷史、社會與文化 -->
2012年時頭孢氨苄名列美國前百大最常使用藥物<ref>{{cite web|last=Bartholow|first=Michael|title=Top 200 Drugs of 2012|url=http://www.pharmacytimes.com/publications/issue/2013/July2013/Top-200-Drugs-of-2012|work=Pharmacy Times|accessdate=2014-04-22|archive-date=2014-05-17|archive-url=https://web.archive.org/web/20140517121247/http://www.pharmacytimes.com/publications/issue/2013/July2013/Top-200-Drugs-of-2012|dead-url=yes}}</ref>，在澳洲則躋身前十五強<ref>{{cite book|title=Australia's Health 2012: The Thirteenth Biennial Health Report of the Australian Institute of Health and Welfare|date=2012|publisher=Australian Institute of Health and Welfare|isbn=9781742493053|page=408|url=http://books.google.ca/books?id=1CazE2WqNBEC&pg=PT424|access-date=2015-01-11|archive-date=2015-01-02|archive-url=https://web.archive.org/web/20150102064642/http://books.google.ca/books?id=1CazE2WqNBEC&pg=PT424|dead-url=no}}</ref>。它在1969-1970年間由[[葛蘭素史克|葛蘭素史克]]與[[禮來公司|禮來]]發現，並分別以'''Keflex'''與'''Ceporex'''為名上市<ref name=McP2007>{{cite book|last=McPherson|first=Edwin M.|title=Pharmaceutical Manufacturing Encyclopedia.|date=2007|publisher=Elsevier|location=Burlington|isbn=9780815518563|page=915|url=http://books.google.ca/books?id=_J2ti4EkYpkC&pg=PA915|edition=3rd|access-date=2015-01-11|archive-date=2014-11-06|archive-url=https://web.archive.org/web/20141106165828/http://books.google.ca/books?id=_J2ti4EkYpkC&pg=PA915|dead-url=no}}</ref><ref>{{cite book|last=Ravina|first=Enrique|title=The evolution of drug discovery : from traditional medicines to modern drugs|date=2011|publisher=Wiley-VCH|location=Weinheim|isbn=9783527326693|page=267|url=http://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA267|edition=1. Aufl.|access-date=2015-01-11|archive-date=2014-11-06|archive-url=https://web.archive.org/web/20141106181950/http://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA267|dead-url=no}}</ref>。今日，市面上已經有許多本藥品的[[通用名藥物|學名藥]]可供選擇，價格也不昂貴<ref name=AHFS2014/><ref>{{cite book|last=Hanlon|first=Geoffrey|title=Essential Microbiology for Pharmacy and Pharmaceutical Science|date=2012|publisher=Wiley|location=Hoboken|isbn=9781118432433|page=140|url=http://books.google.ca/books?id=P4Ucifn76PUC&pg=PT140|author2=Hodges, Norman|access-date=2015-01-11|archive-date=2015-01-02|archive-url=https://web.archive.org/web/20150102064652/http://books.google.ca/books?id=P4Ucifn76PUC&pg=PT140|dead-url=no}}</ref>。本品列名於[[世界衛生組織基本藥物標準清單|世界衛生組織基本藥物標準清單]]上，這張清單列出世界衛生組織建議[[醫療系統|醫療系統]]中應有的最重要的藥物<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=2014-04-22|page=6|date=October 2013|archive-date=2014-04-23|archive-url=https://web.archive.org/web/20140423005004/http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|dead-url=no}}</ref>。

==適應症==
頭孢氨苄可用於治療敏感菌所致[[呼吸道|呼吸道]]（包括[[鼻竇炎|鼻竇炎]]、[[中耳炎|中耳炎]]、[[咽炎|咽炎]]、[[扁桃體炎|扁桃體炎]]及[[肺炎|肺炎]]）、泌尿道、[[皮肤|皮肤]]及軟組織、[[生殖器官|生殖器官]]等部位[[感染|感染]]的治疗。抗菌谱与[[头孢噻吩|头孢噻吩]]、[[头孢噻啶|头孢噻啶]]基本相同，但抗菌效力比两者要弱。

==用法及用量==
成人通常每6小時服250毫克或每8至12小時服500毫克，兒童用量通常以每日每公斤體重服25毫克計，分多次服用。如症狀嚴重，醫生可根據病人情況增加劑量。通常服7至10日，或依醫生指示。

==不良反應==
有些人服藥後出現了不良反應，以下是一些較為常見者：
*腸胃不適，例如[[腹瀉|腹瀉]]、[[噁心|噁心]]及[[嘔吐|嘔吐]]。
*[[頭痛|頭痛]]
*[[過敏反應|過敏反應]]，例如皮膚紅疹、痕癢、[[蕁麻疹|蕁麻疹]]等。如情況嚴重，應立即求醫。

==注意事項==
對頭孢菌素過敏者、[[卟啉症|卟啉症]]（Porphyria）患者禁用頭孢氨苄及其它頭孢菌素。

對[[盤尼西林|盤尼西林]]類抗生素過敏者、腎功能不全者、孕婦或授乳婦女應小心使用頭孢氨苄及其它頭孢菌素。對盤尼西林類抗生素過敏者中，大約10%的人也會對頭孢菌素產生過敏反應。

==外部連結==
*[http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682733.html MedlinePlus Drug Information: Cephalexin] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682733.html |date=20081001223641 }}
*[http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html MedlinePlus Drug Information: Cephalosporins (Systemic)] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html |date=20070202151102 }}

==参见==
*[[頭孢菌素|頭孢菌素]]

== 參考來源 ==
{{reflist|2}}

{{-}}
{{国家基本药物目录/抗微生物药}}

[[Category:頭孢菌素|Category:頭孢菌素]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:礼来公司|Category:礼来公司]]
[[Category:对映纯药物|Category:对映纯药物]]